PAPP Antibodies

Santa Cruz Biotechnology features a diverse variety of PAPP Antibodies for research focused on pregnancy-associated plasma protein A (PAPP-A). PAPP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PAPP-A is a crucial metalloproteinase involved in the regulation of insulin-like growth factor (IGF) activity, playing a significant role in cell growth and development. PAPP-A levels serve as important biomarkers in pregnancy monitoring and cardiovascular disease assessment. Research has shown that PAPP-A expression patterns vary across different tissues and developmental stages. Understanding PAPP-A function continues to reveal new insights into both normal physiological processes and disease mechanisms. Monitoring PAPP-A activity provides valuable information about IGF bioavailability and cellular growth regulation. Current studies indicate promising applications for PAPP-A research in fields ranging from reproductive medicine to cancer biology. Santa Cruz Biotechnology monoclonal antibodies for PAPP-A research support scientists worldwide in advancing our understanding of this significant protein's role in human health and disease.